ClinicalTrials.gov
public full text
Public Domain
Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia
The purpose of this study is to permit the patients with schizophrenia who received Sertindole during a previous randomised trial, study 99824, to continue with this treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia#893591
- A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients#1363183
- A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)#1058670
- Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.#463900
- The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial#874092
Record · ID 1370611
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive